CombiSep Appoints NanoChrom as West Coast Representative
News Dec 20, 2005
CombiSep, Inc. has recently appointed NanoChrom, LLC as its representative for the West Coast.
Mark McDonald, Chief Executive Officer of CombiSep, anticipates the relationship with NanoChrom saying, "I am extremely pleased that NanoChrom will be serving our western U.S. customers."
He adds, "Mr. Terry Ochsner, President of NanoChrom, has extensive sales and service experience in separation science instrumentation and has served in key leadership positions within Hitachi High Technologies America and Merck KGaA."
"Terry’s company will provide vital local representation in a very strategic geographical market for CombiSep’s CE-based life science solutions."
Mr. Terry Ochsner, President of NanoChrom, LLC said, "I believe that CombiSep’s parallel capillary electrophoresis technology has great potential in the life science marketplace, and I look forward to expanding the presence of CombiSep throughout the West Coast."
"I view CombiSep as a key addition to the companies NanoChrom represents in our quest to provide unique system solutions and services to the life science community."
Modified Form of Botox Could Replace Opioids as Treatment for Chronic PainNews
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.READ MORE
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein TargetNews
A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.READ MORE